Scannell Timothy J 4

What Happened

• Timothy J. Scannell, a director of NovoCure Ltd (NVCR), disposed of 2,945 shares on 2026-06-02. The weighted average sale price was $15.77 per share, resulting in proceeds of approximately $46,445. The filing reports the sale as a sell-to-cover mandated to satisfy tax withholding on vested Restricted Stock Units (RSUs), not a discretionary open‑market trade.

Key Details

• Transaction date: 2026-06-02; Form 4 filed 2026-06-03 (timely).
• Transaction type/code: Sale (S) — sell-to-cover for tax withholding.
• Shares sold: 2,945; weighted average price: $15.77; total proceeds ≈ $46,445.
• Price range: trades executed between $15.65 and $15.88 (multiple trades; weighted avg reported).
• Shares owned after transaction: not specified in the provided filing.
• Footnotes: F1 — sale mandated to cover RSU tax withholding per award agreement; F2 — multiple trades produced the reported weighted-average price.

Context

• Sell-to-cover transactions are routine when RSUs vest and are required to cover taxes; they generally do not signal a director's change in view on the company. This was not reported as a discretionary sale under a 10b5-1 plan.